Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • milw
    Director NGS Services, Lucigen
    • Dec 2013
    • 12

    #1

    Webinar Jan 25 '17: What to do when you don’t have enough genomic DNA

    I apologize if this is not the correct forum to post this!

    Join Lucigen for What do when you don't have enough DNA (a Webinar)
    When: Jan 25, 2017 8 am and 11 am CST

    Have you ever wanted to analyze your favorite genomic DNA (gDNA) sample, but didn’t have enough starting material? Perhaps you wanted to perform whole genome sequencing on a single mammalian cell (e.g. a single cancer cell), but couldn’t effectively make your next-gen sequencing fragment library because you didn’t have enough DNA? Or maybe you had enough material from your metagenomic sample to perform one PCR analysis, but you used up the entire sample in that one experiment and couldn’t archive any material for future analyses? If you’ve experienced any of these or other issues due to limiting gDNA samples, then this webinar will help you identify potential solutions.

    Register here for our webinar on What to do when you don’t have enough genomic DNA: https://goo.gl/S7DRtZ
    Scott Monsma
    Sr Scientist at Lucigen

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...